United States Thrombin Inhibitors Market Report 2016

October 2016 | 117 pages | ID: U7CE29D6F43EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Thrombin Inhibitors

Revenue, means the sales value of Thrombin Inhibitors

This report studies sales (consumption) of Thrombin Inhibitors in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Bayer AG
• Pfizer Inc
• Merck
• Sanofi
• Abbott Laboratories
• Johnson & Johnson
• Armetheon Inc
• Microbix Biosystems Inc
• Biovascular Inc
• Baxter International
• Astrazeneca
• Genentech
• Boehringer Ingelheim Gmbh
• Bristol-Myers Squibb CO
• CSL Behring
• ELI LILLY
• Emisphere Technologies
• Sun Pharmaceuticals
• Shire Pharmaceuticals

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Argatroban
• Angiomax
• Iprivask
• Pradaxa
• Activase
• Retavase
• TNKase
• ATryn

Split by applications, this report focuses on sales, market share and growth rate of Thrombin Inhibitors in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Thrombin Inhibitors Market Report 2016

1 THROMBIN INHIBITORS OVERVIEW

1.1 Product Overview and Scope of Thrombin Inhibitors
1.2 Classification of Thrombin Inhibitors
  1.2.1 Argatroban
  1.2.2 Angiomax
  1.2.3 Iprivask
  1.2.4 Pradaxa
  1.2.5 Activase
  1.2.6 Retavase
  1.2.7 TNKase
  1.2.8 ATryn
1.3 Application of Thrombin Inhibitors
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Thrombin Inhibitors (2011-2021)
  1.4.1 United States Thrombin Inhibitors Sales and Growth Rate (2011-2021)
  1.4.2 United States Thrombin Inhibitors Revenue and Growth Rate (2011-2021)

2 UNITED STATES THROMBIN INHIBITORS COMPETITION BY MANUFACTURERS

2.1 United States Thrombin Inhibitors Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Thrombin Inhibitors Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Thrombin Inhibitors Average Price by Manufactures (2015 and 2016)
2.4 Thrombin Inhibitors Market Competitive Situation and Trends
  2.4.1 Thrombin Inhibitors Market Concentration Rate
  2.4.2 Thrombin Inhibitors Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES THROMBIN INHIBITORS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Thrombin Inhibitors Sales and Market Share by Type (2011-2016)
3.2 United States Thrombin Inhibitors Revenue and Market Share by Type (2011-2016)
3.3 United States Thrombin Inhibitors Price by Type (2011-2016)
3.4 United States Thrombin Inhibitors Sales Growth Rate by Type (2011-2016)

4 UNITED STATES THROMBIN INHIBITORS SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Thrombin Inhibitors Sales and Market Share by Application (2011-2016)
4.2 United States Thrombin Inhibitors Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES THROMBIN INHIBITORS MANUFACTURERS PROFILES/ANALYSIS

5.1 Bayer AG
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Thrombin Inhibitors Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Bayer AG Thrombin Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Pfizer Inc
  5.2.2 Thrombin Inhibitors Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Pfizer Inc Thrombin Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Merck
  5.3.2 Thrombin Inhibitors Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Merck Thrombin Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Sanofi
  5.4.2 Thrombin Inhibitors Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Sanofi Thrombin Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Abbott Laboratories
  5.5.2 Thrombin Inhibitors Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Abbott Laboratories Thrombin Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Johnson & Johnson
  5.6.2 Thrombin Inhibitors Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Johnson & Johnson Thrombin Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Armetheon Inc
  5.7.2 Thrombin Inhibitors Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Armetheon Inc Thrombin Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Microbix Biosystems Inc
  5.8.2 Thrombin Inhibitors Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Microbix Biosystems Inc Thrombin Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Biovascular Inc
  5.9.2 Thrombin Inhibitors Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Biovascular Inc Thrombin Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Baxter International
  5.10.2 Thrombin Inhibitors Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Baxter International Thrombin Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview
5.11 Astrazeneca
5.12 Genentech
5.13 Boehringer Ingelheim Gmbh
5.14 Bristol-Myers Squibb CO
5.15 CSL Behring
5.16 ELI LILLY
5.17 Emisphere Technologies
5.18 Sun Pharmaceuticals
5.19 Shire Pharmaceuticals

6 THROMBIN INHIBITORS MANUFACTURING COST ANALYSIS

6.1 Thrombin Inhibitors Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Thrombin Inhibitors

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Thrombin Inhibitors Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Thrombin Inhibitors Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES THROMBIN INHIBITORS MARKET FORECAST (2016-2021)

10.1 United States Thrombin Inhibitors Sales, Revenue Forecast (2016-2021)
10.2 United States Thrombin Inhibitors Sales Forecast by Type (2016-2021)
10.3 United States Thrombin Inhibitors Sales Forecast by Application (2016-2021)
10.4 Thrombin Inhibitors Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Thrombin Inhibitors
Table Classification of Thrombin Inhibitors
Figure United States Sales Market Share of Thrombin Inhibitors by Type in 2015
Figure Argatroban Picture
Figure Angiomax Picture
Figure Iprivask Picture
Figure Pradaxa Picture
Figure Activase Picture
Figure Retavase Picture
Figure TNKase Picture
Figure ATryn Picture
Table Application of Thrombin Inhibitors
Figure United States Sales Market Share of Thrombin Inhibitors by Application in 2015
Figure United States Thrombin Inhibitors Sales and Growth Rate (2011-2021)
Figure United States Thrombin Inhibitors Revenue and Growth Rate (2011-2021)
Table United States Thrombin Inhibitors Sales of Key Manufacturers (2015 and 2016)
Table United States Thrombin Inhibitors Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Thrombin Inhibitors Sales Share by Manufacturers
Figure 2016 Thrombin Inhibitors Sales Share by Manufacturers
Table United States Thrombin Inhibitors Revenue by Manufacturers (2015 and 2016)
Table United States Thrombin Inhibitors Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Thrombin Inhibitors Revenue Share by Manufacturers
Table 2016 United States Thrombin Inhibitors Revenue Share by Manufacturers
Table United States Market Thrombin Inhibitors Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Thrombin Inhibitors Average Price of Key Manufacturers in 2015
Figure Thrombin Inhibitors Market Share of Top 3 Manufacturers
Figure Thrombin Inhibitors Market Share of Top 5 Manufacturers
Table United States Thrombin Inhibitors Sales by Type (2011-2016)
Table United States Thrombin Inhibitors Sales Share by Type (2011-2016)
Figure United States Thrombin Inhibitors Sales Market Share by Type in 2015
Table United States Thrombin Inhibitors Revenue and Market Share by Type (2011-2016)
Table United States Thrombin Inhibitors Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Thrombin Inhibitors by Type (2011-2016)
Table United States Thrombin Inhibitors Price by Type (2011-2016)
Figure United States Thrombin Inhibitors Sales Growth Rate by Type (2011-2016)
Table United States Thrombin Inhibitors Sales by Application (2011-2016)
Table United States Thrombin Inhibitors Sales Market Share by Application (2011-2016)
Figure United States Thrombin Inhibitors Sales Market Share by Application in 2015
Table United States Thrombin Inhibitors Sales Growth Rate by Application (2011-2016)
Figure United States Thrombin Inhibitors Sales Growth Rate by Application (2011-2016)
Table Bayer AG Basic Information List
Table Bayer AG Thrombin Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Bayer AG Thrombin Inhibitors Sales Market Share (2011-2016)
Table Pfizer Inc Basic Information List
Table Pfizer Inc Thrombin Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Inc Thrombin Inhibitors Sales Market Share (2011-2016)
Table Merck Basic Information List
Table Merck Thrombin Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck Thrombin Inhibitors Sales Market Share (2011-2016)
Table Sanofi Basic Information List
Table Sanofi Thrombin Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi Thrombin Inhibitors Sales Market Share (2011-2016)
Table Abbott Laboratories Basic Information List
Table Abbott Laboratories Thrombin Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
Table Abbott Laboratories Thrombin Inhibitors Sales Market Share (2011-2016)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Thrombin Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
Table Johnson & Johnson Thrombin Inhibitors Sales Market Share (2011-2016)
Table Armetheon Inc Basic Information List
Table Armetheon Inc Thrombin Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
Table Armetheon Inc Thrombin Inhibitors Sales Market Share (2011-2016)
Table Microbix Biosystems Inc Basic Information List
Table Microbix Biosystems Inc Thrombin Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
Table Microbix Biosystems Inc Thrombin Inhibitors Sales Market Share (2011-2016)
Table Biovascular Inc Basic Information List
Table Biovascular Inc Thrombin Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
Table Biovascular Inc Thrombin Inhibitors Sales Market Share (2011-2016)
Table Baxter International Basic Information List
Table Baxter International Thrombin Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
Table Baxter International Thrombin Inhibitors Sales Market Share (2011-2016)
Table Astrazeneca Basic Information List
Table Astrazeneca Thrombin Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
Table Astrazeneca Thrombin Inhibitors Sales Market Share (2011-2016)
Table Genentech Basic Information List
Table Genentech Thrombin Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
Table Genentech Thrombin Inhibitors Sales Market Share (2011-2016)
Table Boehringer Ingelheim Gmbh Basic Information List
Table Boehringer Ingelheim Gmbh Thrombin Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boehringer Ingelheim Gmbh Thrombin Inhibitors Sales Market Share (2011-2016)
Table Bristol-Myers Squibb CO Basic Information List
Table Bristol-Myers Squibb CO Thrombin Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bristol-Myers Squibb CO Thrombin Inhibitors Sales Market Share (2011-2016)
Table CSL Behring Basic Information List
Table CSL Behring Thrombin Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
Table CSL Behring Thrombin Inhibitors Sales Market Share (2011-2016)
Table ELI LILLY Basic Information List
Table ELI LILLY Thrombin Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
Table ELI LILLY Thrombin Inhibitors Sales Market Share (2011-2016)
Table Emisphere Technologies Basic Information List
Table Emisphere Technologies Thrombin Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
Table Emisphere Technologies Thrombin Inhibitors Sales Market Share (2011-2016)
Table Sun Pharmaceuticals Basic Information List
Table Sun Pharmaceuticals Thrombin Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sun Pharmaceuticals Thrombin Inhibitors Sales Market Share (2011-2016)
Table Shire Pharmaceuticals Basic Information List
Table Shire Pharmaceuticals Thrombin Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
Table Shire Pharmaceuticals Thrombin Inhibitors Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Thrombin Inhibitors
Figure Manufacturing Process Analysis of Thrombin Inhibitors
Figure Thrombin Inhibitors Industrial Chain Analysis
Table Raw Materials Sources of Thrombin Inhibitors Major Manufacturers in 2015
Table Major Buyers of Thrombin Inhibitors
Table Distributors/Traders List
Figure United States Thrombin Inhibitors Production and Growth Rate Forecast (2016-2021)
Figure United States Thrombin Inhibitors Revenue and Growth Rate Forecast (2016-2021)
Table United States Thrombin Inhibitors Production Forecast by Type (2016-2021)
Table United States Thrombin Inhibitors Consumption Forecast by Application (2016-2021)